Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
Globe Life Inc. (GL) – Form 4, filed 31-Jul-2025
Senior Vice-President & Chief Accounting Officer Michael Shane Henrie reported an option exercise and related sale on 29-Jul-2025:
- Option exercise (Code M): 3,250 shares at a $103.23 strike (grant dated 23-Feb-2025, expiry 23-Feb-2029).
- Open-market sale (Code S): 3,250 shares sold at a volume-weighted average price of $139.7526 (individual prices $139.67–$139.90).
Net effect on ownership
- Direct common stock declined from 6,290 to 3,040 shares (-3,250 shares).
- Indirect holdings remain 152.182 shares in the 401(k) plan.
- No remaining derivative securities from the exercised grant.
The transaction generated a spread of $36.52 per share between exercise price and sale price, indicating a gross pre-tax gain of roughly $0.12 million. Henrie continues to hold approximately 3.2 k direct shares plus 152 plan shares.
Globe Life Inc. (GL) – Form 144 notice of proposed insider sale
Executive Frank Svoboda intends to sell up to 25,000 common shares through Apex Clearing on or about 30 Jul 2025. The shares were obtained via stock-option exercise on 28 Feb 2019. Using the filing’s stated aggregate market value of $3.55 million, the transaction equals roughly 0.03 % of the 81.0 million shares outstanding.
Svoboda has already sold 30,000 shares in the past three months—15,000 on 20 May 2025 and 15,000 on 4 Jun 2025—realizing gross proceeds of $1.47 million. If the newly noticed sale is completed, total disposals would reach 55,000 shares over the May-July 2025 period.
Rule 144 filings are intent notices rather than confirmations; execution price and timing can change. Nevertheless, consecutive sales by a senior officer may influence investor sentiment, though the absolute amount is immaterial to share count.
Globe Life Inc. (GL) – Form 144 filing
An undisclosed affiliate has notified the SEC of an intention to sell 15,000 common shares via Apex Clearing on or about 25 Jul 2025. At an aggregate market value of $1.97 million, the indicated price is roughly $131.5 per share. The shares were obtained through a stock-option exercise on 26 Feb 2020 and equal just 0.019 % of Globe Life’s 80.8 million shares outstanding.
Rule 144 filings serve as advance notice; the sale may or may not occur and no immediate cash proceeds accrue to the company. Given the limited size relative to float and the absence of new operational disclosures, the transaction is viewed as a routine insider liquidity move with minimal impact on Globe Life’s capital structure, earnings, or valuation.